Biodexa Pharmaceuticals American Depositary Shs Stock Forecast
NASDAQ: BDRXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
Market open · Delayed 15 min · as of Oct 9, 12:17 PM ET
BDRX analyst consensus
Consensus
none
Avg. price target
$8.91+1858.24%
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
The average 12-month price target is $8.91, with a high estimate of $8.91 and a low estimate of $8.91. The average target implies upside of 1858.2% from the current price of $0.455. The spread between the highest and lowest targets is 0.0%, a relatively narrow range.
Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for BDRX.
Summary generated from market data by MetaCap's automated system. Methodology
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $8.91 | +1858.24% |
| Average target | $8.91 | +1858.24% |
| High target | $8.91 | +1858.24% |